Bridgeworth’s Elevance Health ELV Stock Holding History

Bridgeworth’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$255K	Sell	540 -11	-2%	-$5.09K	0.03%	155
2023 Q3	$240K	Buy	551 +9	+2%	+$4.08K	0.03%	148
2023 Q2	$241K	Buy	542 +2	+0.4%	+$923	0.03%	151
2023 Q1	$249K	Hold	540	–	–	0.03%	140
2022 Q4	$277K	Sell	540 -5	-0.9%	-$2.54K	0.04%	129
2022 Q3	$248K	Hold	545	–	–	0.06%	119
2022 Q2	$263K	Hold	545	–	–	0.06%	118
2022 Q1	$268K	Hold	545	–	–	0.06%	122
2021 Q4	$253K	Sell	545 -5	-0.9%	-$2.1K	0.06%	136
2021 Q3	$205K	Buy	550 +1	+0.2%	+$380	0.06%	131
2021 Q2	$210K	Buy	+549	New	+$210K	0.06%	123
2019 Q1	–	Sell	-858	Closed	-$221K	–	146
2018 Q4	$221K	Sell	858 -5	-0.6%	-$1.38K	0.13%	107
2018 Q3	$234K	Buy	863 +17	+2%	+$4.41K	0.13%	109
2018 Q2	$201K	Buy	+846	New	+$196K	0.09%	131

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bridgeworth's ELV Position: Q4 2023 in Review

Bridgeworth reduced its Elevance Health (ELV) stake by 2% in Q4 2023, selling an estimated $5.09K and leaving 540 shares worth $255K. The position accounts for 0.03% of the portfolio, ranked #155.

Bridgeworth first reported a position in ELV in Q2 2018 and has held it in 14 quarters since. The position peaked at $277K in Q4 2022. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

Bridgeworth held 540 shares of Elevance Health worth $255K as of Q4 2023.
Bridgeworth sold 11 Elevance Health shares in Q4 2023, an estimated $5.09K.
Elevance Health made up 0.03% of Bridgeworth's portfolio in Q4 2023, its #155 holding.
Bridgeworth first reported a position in Elevance Health in Q2 2018 and has held it in 14 quarters since.
Bridgeworth's Elevance Health position peaked at $277K in Q4 2022.
1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Bridgeworth's 13F filing for Q4 2023, filed 26 Jan 2024.